[HTML][HTML] Current advances in the development of SARS-CoV-2 vaccines

A Awadasseid, Y Wu, Y Tanaka… - International journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is now a global pandemic that has wreaked havoc …

Association of COVID-19 with comorbidities: An update

S Chatterjee, LV Nalla, M Sharma… - ACS Pharmacology & …, 2023 - ACS Publications
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …

Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection

M Akbarzadeh-Khiavi, M Torabi, L Rahbarnia, A Safary - Infection, 2022 - Springer
Abstract Purpose The Coronavirus disease 2019 (COVID-19) pandemic is one of the most
devastating global problems. Regarding the lack of disease-specific treatments, repurposing …

Drug repurposing strategies and key challenges for COVID-19 management

S Mule, A Singh, K Greish, A Sahebkar… - Journal of Drug …, 2022 - Taylor & Francis
COVID-19 is a clinical outcome of viral infection emerged due to strain of beta coronavirus
which attacks the type-2 pneumocytes in alveoli via angiotensin-converting enzyme 2 …

Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection

ME Baldeón, A Maldonado… - Transfusion …, 2022 - Wiley Online Library
Abstract Introduction South America is one of the regions most affected by the COVID‐19
pandemic. Specific and affordable treatments are needed to treat SARS‐CoV‐2 infection …

[HTML][HTML] Drug repurposing against coronavirus disease 2019 (COVID-19): A review

L Luo, Q Qiu, F Huang, K Liu, Y Lan, X Li… - Journal of …, 2021 - Elsevier
Since December 2019, severe acute respiratory syndrome coronavirus 2 has been found to
be the culprit in the coronavirus disease 2019 (COVID-19), causing a global pandemic …

[HTML][HTML] Analysis of COVID-19 prevention and treatment in Taiwan

YJ Chiu, JH Chiang, CW Fu, MJ Hour, HA Ha… - Biomedicine, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) has been spreading worldwide with a mind-
boggling speed. According to a statement from World Health Organization (WHO), COVID …

Transcriptomic profiles reveal downregulation of low-density lipoprotein particle receptor pathway activity in patients surviving severe COVID-19

I Vlasov, A Panteleeva, T Usenko, M Nikolaev… - Cells, 2021 - mdpi.com
To assess the biology of the lethal endpoint in patients with SARS-CoV-2 infection, we
compared the transcriptional response to the virus in patients who survived or died during …

Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis

RA Abeldano Zuniga, SM Coca… - Therapeutic …, 2021 - journals.sagepub.com
The aim was to assess the clinical effectiveness of drugs used in hospitalized patients with
COVID-19 infection. We conducted a systematic review of randomized clinical trials …

[HTML][HTML] Association between COVID-19 and male fertility: systematic review and meta-analysis of observational studies

S Wang, A Zhang, Y Pan, L Liu, S Niu… - The World Journal of …, 2023 - ncbi.nlm.nih.gov
Purpose Whether COVID-19 reduces male fertility remains requires further investigation.
This meta-analysis and systematic review evaluated the impact of COVID-19 on male …